vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

BayFirst Financial Corp. is the larger business by last-quarter revenue ($10.3M vs $5.5M, roughly 1.9× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -55.0%, a 52.4% gap on every dollar of revenue. Over the past eight quarters, IMMUCELL CORP's revenue compounded faster (3.9% CAGR vs -29.6%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

BAFN vs ICCC — Head-to-Head

Bigger by revenue
BAFN
BAFN
1.9× larger
BAFN
$10.3M
$5.5M
ICCC
Higher net margin
ICCC
ICCC
52.4% more per $
ICCC
-2.5%
-55.0%
BAFN
Faster 2-yr revenue CAGR
ICCC
ICCC
Annualised
ICCC
3.9%
-29.6%
BAFN

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BAFN
BAFN
ICCC
ICCC
Revenue
$10.3M
$5.5M
Net Profit
$-5.7M
$-139.7K
Gross Margin
42.9%
Operating Margin
0.4%
Net Margin
-55.0%
-2.5%
Revenue YoY
-8.4%
Net Profit YoY
-130.6%
80.1%
EPS (diluted)
$-1.48
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
ICCC
ICCC
Q1 26
$10.3M
Q4 25
$11.2M
Q3 25
$10.2M
$5.5M
Q2 25
$23.1M
$6.4M
Q1 25
$19.8M
$8.1M
Q4 24
$32.9M
$7.8M
Q3 24
$21.7M
$6.0M
Q2 24
$20.8M
$5.5M
Net Profit
BAFN
BAFN
ICCC
ICCC
Q1 26
$-5.7M
Q4 25
$-2.5M
Q3 25
$-18.9M
$-139.7K
Q2 25
$-1.2M
$501.9K
Q1 25
$-335.0K
$1.4M
Q4 24
$9.8M
Q3 24
$1.1M
$-701.7K
Q2 24
$866.0K
$-1.5M
Gross Margin
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
Q3 25
42.9%
Q2 25
43.7%
Q1 25
41.6%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Operating Margin
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
-25.3%
Q3 25
-253.0%
0.4%
Q2 25
-7.1%
8.8%
Q1 25
-2.3%
13.9%
Q4 24
8.0%
Q3 24
7.1%
-9.6%
Q2 24
5.9%
-25.3%
Net Margin
BAFN
BAFN
ICCC
ICCC
Q1 26
-55.0%
Q4 25
-22.1%
Q3 25
-184.7%
-2.5%
Q2 25
-5.3%
7.8%
Q1 25
-1.7%
17.9%
Q4 24
91.8%
Q3 24
5.2%
-11.7%
Q2 24
4.2%
-28.0%
EPS (diluted)
BAFN
BAFN
ICCC
ICCC
Q1 26
$-1.48
Q4 25
$-0.71
Q3 25
$-4.66
$-0.02
Q2 25
$-0.39
$0.06
Q1 25
$-0.17
$0.16
Q4 24
$2.21
$0.09
Q3 24
$0.18
$-0.09
Q2 24
$0.12
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$134.5M
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$81.9M
$29.8M
Total Assets
$1.2B
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
ICCC
ICCC
Q1 26
$134.5M
Q4 25
$207.0M
Q3 25
$118.5M
$3.9M
Q2 25
$77.3M
Q1 25
$63.2M
Q4 24
$77.8M
$3.8M
Q3 24
$64.4M
Q2 24
$60.8M
$1.3M
Total Debt
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Stockholders' Equity
BAFN
BAFN
ICCC
ICCC
Q1 26
$81.9M
Q4 25
$87.6M
Q3 25
$89.7M
$29.8M
Q2 25
$108.2M
$29.9M
Q1 25
$110.1M
$29.0M
Q4 24
$110.9M
$27.5M
Q3 24
$102.3M
$26.4M
Q2 24
$101.0M
$23.5M
Total Assets
BAFN
BAFN
ICCC
ICCC
Q1 26
$1.2B
Q4 25
$1.3B
Q3 25
$1.3B
$45.7M
Q2 25
$1.3B
$46.7M
Q1 25
$1.3B
$45.6M
Q4 24
$1.3B
$45.1M
Q3 24
$1.2B
$44.4M
Q2 24
$1.2B
$41.9M
Debt / Equity
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
ICCC
ICCC
Operating Cash FlowLast quarter
$-1.2M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-32.3%
Capex IntensityCapex / Revenue
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
$285.3M
Q3 25
$47.3M
$-1.2M
Q2 25
$63.3M
$1.6M
Q1 25
$74.2M
$1.6M
Q4 24
$390.5M
$-3.1K
Q3 24
$90.8M
$-639.3K
Q2 24
$78.8M
$581.8K
Free Cash Flow
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
$285.0M
Q3 25
$47.3M
$-1.8M
Q2 25
$63.1M
$1.4M
Q1 25
$74.1M
$1.2M
Q4 24
$388.8M
$-199.3K
Q3 24
$90.5M
$-727.7K
Q2 24
$78.4M
$471.0K
FCF Margin
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
2554.2%
Q3 25
462.2%
-32.3%
Q2 25
272.7%
22.4%
Q1 25
375.1%
15.4%
Q4 24
1180.9%
-2.6%
Q3 24
416.5%
-12.1%
Q2 24
376.1%
8.6%
Capex Intensity
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
2.7%
Q3 25
0.1%
10.8%
Q2 25
0.8%
2.4%
Q1 25
0.4%
4.1%
Q4 24
5.1%
2.5%
Q3 24
1.5%
1.5%
Q2 24
1.9%
2.0%
Cash Conversion
BAFN
BAFN
ICCC
ICCC
Q1 26
Q4 25
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
39.95×
Q3 24
79.85×
Q2 24
90.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAFN
BAFN

Net Interest Income$9.4M91%
Noninterest Income$884.0K9%

ICCC
ICCC

Segment breakdown not available.

Related Comparisons